Trade Summary

Yesterday, Wai Conrad, serving as CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 220,426 shares at $3.99 per share, for a total transaction value of $879,499.74. Following this transaction, Wai Conrad now holds 1,390,056 shares of CLOV.

This sale represents a 13.69% decrease in Wai Conrad's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 6:40 PM ET, meaning the disclosure happened on the same day as the trade.

CLOVER HEALTH INVESTMENTS, CORP. /DE operates in the HEALTHCARE sector, specifically within the HEALTHCARE PLANS industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.